Evommune
evommune.com
Actively hiring
Drug Discovery
As featured in
View 2 jobs
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
News
Analysts Have Conflicting Sentiments on These NA Companies: Evommune, Inc. (EVMN) and Douglas AG (OtherDOUDF)
Detailed price information for Evommune Inc (EVMN-N) from The Globe and Mail including charting and trades.
Read more
Report
Report
Report
- Company Announcement - FT.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Read more
Report
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine
Read more
Report
Evommune Starts Making Case to Challenge Dominance of Sanofi's Dupixent in Atopic Dermatitis
Evommune's EVO301 met the goals of a placebo-controlled Phase 2a study in atopic dermatitis. The biologic drug neutralizes a signaling protein involved in multiple inflammatory pathways, which could differentiate it from the blockbuster Sanofi and Regener
Read more
Report
Evommune: $50 Million Secured To Develop New Ways To Treat Inflammatory Diseases
Evommune - a clinical-stage biotechnology company discovering and developing new ways to treat inflammatory diseases - announced the completion of a $50 million Series B financing. The funding round was co-led by new investor Arix Bioscience and current i
Read more
Report
Tech stack
Technologies named in job postings at Evommune over the last 12 months, by layer, with the share of postings for each.
Technologies in use
3
Postings analysed
1
Stack modernity
57/100
Practices & domains
Chromatography
GMP
Mass Spectrometry
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$280k
Typical range
$260k – $375k
Open positions
3
3
Jobs
Senior
33.3%
Architect
66.7%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 1 | $280k | $280k |
| Architect | 2 | $318k | $260k – $375k |
Highest paying role
Head of Regulatory Affairs
$375k
Normalized to USD per year
People
Eugene Bauer
Executive Officer, Director
Kyle Carver
Executive Officer
Gregory Moss
Executive Officer
Jeegar Patel
Executive Officer
Janice Drew
Executive Officer
Luis Pena
Executive Officer, Director
Derek DiRocco
Director
Felice Verduyn-van Weegen
Director
Robert Hopfner
Director
David Cohen
Director
Francois Beaubien
Director
Benjamin McGraw
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
55/100
Growing
Open positions
3
0 opened / 0 closed in 30 days
Median time-to-fill
40 days
faster than 33% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
50% ▼
Biotech
50% ▼
Activity Timeline
Added Mass Spectrometry to stack
Oct 2026
Added GMP to stack
Oct 2026
Added Chromatography to stack
Oct 2026
Added Microsoft Office to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
1
Busiest office
Palo Alto
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Palo Alto
United States
HQ
Let us know if you want to learn more about Evommune.
3 open roles 2 posted in 90 days 50-200 est. staff $305k Avg Salary
hires for Biotech, Public Policy
1891 Page Mill Road, Palo Alto, CA 94304
New York
United States
Regional office
New York Office
350 Fifth Avenue
Jobs
$190k – $260k per year • In office • Full-Time • 12+ years exp • PhD • Palo Alto
Mass Spectrometry
Chromatography
GMP
Apply
Apply